推薦產品
等級
certified reference material
pharmaceutical secondary standard
品質等級
agency
traceable to Ph. Eur. M0253000
traceable to USP 1379059
API 家族
mefloquine
CofA
current certificate can be downloaded
包裝
pkg of 1 g
技術
HPLC: suitable
gas chromatography (GC): suitable
應用
pharmaceutical (small molecule)
形式
neat
儲存溫度
2-30°C
SMILES 字串
Cl[H].[H][C@@]1(CCCCN1)[C@@H](O)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F
InChI
1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H/t12-,15+;/m1./s1
InChI 密鑰
WESWYMRNZNDGBX-YLCXCWDSSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to in-house working standards.
應用
Mefloquine Hydrochloride may be used as a pharmaceutical reference standard for the determination of mefloquine in pharmaceutical formulations and plasma samples by various chromatography techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
生化/生理作用
间隙连接通道Cx36和Cx50的阻断剂。
分析報告
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他說明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
腳註
To see an example of a Certificate of Analysis for this material enter LRAC3945 in the slot below. This is an example certificate only and may not be the lot that you receive.
訊號詞
Warning
危險聲明
危險分類
Acute Tox. 4 Oral
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
客戶也查看了
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space.
Journal of Chromatography A, 1218(31), 5205-5215 (2011)
Development of a generic micellar electrokinetic chromatography method for the separation of 15 antimalarial drugs as a tool to detect medicine counterfeiting.
Electrophoresis, 33(11), 1669-1678 (2012)
Screening study of SFC critical method parameters for the determination of pharmaceutical compounds.
Journal of Pharmaceutical and Biomedical Analysis, 125(31), 339-354 (2016)
Development and validation of a reversed-phase LC method for analysing potentially counterfeit antimalarial medicines.
Journal of Pharmaceutical and Biomedical Analysis, 42(1), 132-135 (2006)
An analytical method with a single extraction procedure and two separate high performance liquid chromatographic systems for the determination of artesunate, dihydroartemisinin and mefloquine in human plasma for application in clinical pharmacological studies of the drug combination.
Journal of Chromatography. B, Biomedical Sciences and Applications, 857(2), 308-314 (2007)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務